drugset / Trial / NCT05095701
An Immunity Persistence Study of Live Attenuated Varicella Vaccine
Non-randomizedParallel-groupOpen-labelPrevention
Summary
This an open phase Ⅳ clinical trial of live attenuated varicella vaccines manufactured by Sinovac (Dalian) Vaccine Technology Co., Ltd .The purpose of this study is to evaluate the immunity persistence of live attenuated varicella vaccine at 5 and 8 years after primary immunization with live attenuated varicella vaccine.
Timeline
- Start
- 2021-12-18
- Primary completion
- 2021-12-19
- Completion
- 2025-10-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Live Attenuated Varicella Vaccine | Vaccine | 0.5 ml | — |